ILLUMINA INC (ILMN) Stock Fundamental Analysis

NASDAQ:ILMN • US4523271090

134.46 USD
+7.06 (+5.54%)
At close: Feb 27, 2026
134.46 USD
0 (0%)
After Hours: 2/27/2026, 5:49:56 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to ILMN. ILMN was compared to 58 industry peers in the Life Sciences Tools & Services industry. ILMN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ILMN has a decent growth rate and is not valued too expensively. This makes ILMN very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • ILMN had positive earnings in the past year.
  • ILMN had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: ILMN reported negative net income in multiple years.
  • Each year in the past 5 years ILMN had a positive operating cash flow.
ILMN Yearly Net Income VS EBIT VS OCF VS FCFILMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • The Return On Assets of ILMN (12.79%) is better than 94.83% of its industry peers.
  • With an excellent Return On Equity value of 31.22%, ILMN belongs to the best of the industry, outperforming 96.55% of the companies in the same industry.
  • ILMN's Return On Invested Capital of 13.63% is amongst the best of the industry. ILMN outperforms 91.38% of its industry peers.
Industry RankSector Rank
ROA 12.79%
ROE 31.22%
ROIC 13.63%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ILMN Yearly ROA, ROE, ROICILMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40 -60

1.3 Margins

  • ILMN has a Profit Margin of 19.57%. This is amongst the best in the industry. ILMN outperforms 93.10% of its industry peers.
  • In the last couple of years the Profit Margin of ILMN has remained more or less at the same level.
  • With an excellent Operating Margin value of 20.29%, ILMN belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ILMN has grown nicely.
  • ILMN has a Gross Margin of 66.61%. This is amongst the best in the industry. ILMN outperforms 89.66% of its industry peers.
  • ILMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.29%
PM (TTM) 19.57%
GM 66.61%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
ILMN Yearly Profit, Operating, Gross MarginsILMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • ILMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ILMN has less shares outstanding
  • ILMN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ILMN has an improved debt to assets ratio.
ILMN Yearly Shares OutstandingILMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
ILMN Yearly Total Debt VS Total AssetsILMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ILMN has an Altman-Z score of 4.30. This indicates that ILMN is financially healthy and has little risk of bankruptcy at the moment.
  • ILMN has a better Altman-Z score (4.30) than 84.48% of its industry peers.
  • The Debt to FCF ratio of ILMN is 2.14, which is a good value as it means it would take ILMN, 2.14 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 2.14, ILMN belongs to the best of the industry, outperforming 87.93% of the companies in the same industry.
  • A Debt/Equity ratio of 0.55 indicates that ILMN is somewhat dependend on debt financing.
  • ILMN has a worse Debt to Equity ratio (0.55) than 65.52% of its industry peers.
  • Even though the debt/equity ratio score it not favorable for ILMN, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.14
Altman-Z 4.3
ROIC/WACC1.28
WACC10.65%
ILMN Yearly LT Debt VS Equity VS FCFILMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 2.08 indicates that ILMN has no problem at all paying its short term obligations.
  • ILMN has a Current ratio (2.08) which is comparable to the rest of the industry.
  • ILMN has a Quick Ratio of 1.72. This is a normal value and indicates that ILMN is financially healthy and should not expect problems in meeting its short term obligations.
  • ILMN has a Quick ratio (1.72) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.08
Quick Ratio 1.72
ILMN Yearly Current Assets VS Current LiabilitesILMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • ILMN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.96%, which is quite impressive.
  • ILMN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.51% yearly.
  • The Revenue has decreased by -0.66% in the past year.
  • ILMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.04% yearly.
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.14% on average over the next years. This is quite good.
  • ILMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.06% yearly.
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue Next Year5.78%
Revenue Next 2Y5.64%
Revenue Next 3Y5.85%
Revenue Next 5Y6.06%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ILMN Yearly Revenue VS EstimatesILMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
ILMN Yearly EPS VS EstimatesILMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 27.72, which means the current valuation is very expensive for ILMN.
  • Compared to the rest of the industry, the Price/Earnings ratio of ILMN indicates a somewhat cheap valuation: ILMN is cheaper than 70.69% of the companies listed in the same industry.
  • ILMN's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.10.
  • The Price/Forward Earnings ratio is 25.97, which means the current valuation is very expensive for ILMN.
  • Based on the Price/Forward Earnings ratio, ILMN is valued a bit cheaper than 74.14% of the companies in the same industry.
  • ILMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 27.72
Fwd PE 25.97
ILMN Price Earnings VS Forward Price EarningsILMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ILMN is valued cheaper than 81.03% of the companies in the same industry.
  • 84.48% of the companies in the same industry are more expensive than ILMN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.07
EV/EBITDA 17.04
ILMN Per share dataILMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of ILMN may justify a higher PE ratio.
PEG (NY)4.11
PEG (5Y)18.37
EPS Next 2Y10.5%
EPS Next 3Y9.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ILMN!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ILLUMINA INC

NASDAQ:ILMN (2/27/2026, 5:49:56 PM)

After market: 134.46 0 (0%)

134.46

+7.06 (+5.54%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-06
Inst Owners104.7%
Inst Owner Change-1.16%
Ins Owners0.17%
Ins Owner Change-0.31%
Market Cap20.55B
Revenue(TTM)4.34B
Net Income(TTM)850.00M
Analysts72.31
Price Target135.91 (1.08%)
Short Float %5.44%
Short Ratio4.24
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.07%
Min EPS beat(2)7.62%
Max EPS beat(2)12.52%
EPS beat(4)4
Avg EPS beat(4)9.19%
Min EPS beat(4)1.33%
Max EPS beat(4)15.27%
EPS beat(8)6
Avg EPS beat(8)14.27%
EPS beat(12)10
Avg EPS beat(12)229.92%
EPS beat(16)13
Avg EPS beat(16)175.39%
Revenue beat(2)1
Avg Revenue beat(2)1.24%
Min Revenue beat(2)-0.28%
Max Revenue beat(2)2.75%
Revenue beat(4)1
Avg Revenue beat(4)0.08%
Min Revenue beat(4)-1.21%
Max Revenue beat(4)2.75%
Revenue beat(8)3
Avg Revenue beat(8)-0.09%
Revenue beat(12)5
Avg Revenue beat(12)-0.28%
Revenue beat(16)5
Avg Revenue beat(16)-0.88%
PT rev (1m)2.77%
PT rev (3m)12.81%
EPS NQ rev (1m)-6.53%
EPS NQ rev (3m)-5.22%
EPS NY rev (1m)0.04%
EPS NY rev (3m)2.37%
Revenue NQ rev (1m)1.3%
Revenue NQ rev (3m)1.48%
Revenue NY rev (1m)3.03%
Revenue NY rev (3m)3.79%
Valuation
Industry RankSector Rank
PE 27.72
Fwd PE 25.97
P/S 4.73
P/FCF 22.07
P/OCF 19.04
P/B 7.55
P/tB 14.68
EV/EBITDA 17.04
EPS(TTM)4.85
EY3.61%
EPS(NY)5.18
Fwd EY3.85%
FCF(TTM)6.09
FCFY4.53%
OCF(TTM)7.06
OCFY5.25%
SpS28.42
BVpS17.82
TBVpS9.16
PEG (NY)4.11
PEG (5Y)18.37
Graham Number44.1
Profitability
Industry RankSector Rank
ROA 12.79%
ROE 31.22%
ROCE 17.41%
ROIC 13.63%
ROICexc 20.13%
ROICexgc 32.79%
OM 20.29%
PM (TTM) 19.57%
GM 66.61%
FCFM 21.44%
ROA(3y)-6.03%
ROA(5y)-9.81%
ROE(3y)-13.51%
ROE(5y)-20.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y1.94%
ROICexgc growth 5Y5.2%
ROICexc growth 3Y74.03%
ROICexc growth 5Y4.4%
OM growth 3Y36.82%
OM growth 5Y2.01%
PM growth 3YN/A
PM growth 5Y-0.68%
GM growth 3Y0.64%
GM growth 5Y-0.57%
F-Score8
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 2.14
Debt/EBITDA 1.29
Cap/Depr 54.81%
Cap/Sales 3.41%
Interest Coverage 9.27
Cash Conversion 93.74%
Profit Quality 109.53%
Current Ratio 2.08
Quick Ratio 1.72
Altman-Z 4.3
F-Score8
WACC10.65%
ROIC/WACC1.28
Cap/Depr(3y)45.45%
Cap/Depr(5y)67.5%
Cap/Sales(3y)3.56%
Cap/Sales(5y)5.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.96%
EPS 3Y31.77%
EPS 5Y1.51%
EPS Q2Q%56.98%
EPS Next Y6.75%
EPS Next 2Y10.5%
EPS Next 3Y9.64%
EPS Next 5Y12.14%
Revenue 1Y (TTM)-0.66%
Revenue growth 3Y-1.78%
Revenue growth 5Y6.04%
Sales Q2Q%4.98%
Revenue Next Year5.78%
Revenue Next 2Y5.64%
Revenue Next 3Y5.85%
Revenue Next 5Y6.06%
EBIT growth 1Y36.38%
EBIT growth 3Y34.38%
EBIT growth 5Y8.17%
EBIT Next Year30.31%
EBIT Next 3Y19.36%
EBIT Next 5Y16.64%
FCF growth 1Y31.31%
FCF growth 3YN/A
FCF growth 5Y0.88%
OCF growth 1Y28.91%
OCF growth 3Y40.15%
OCF growth 5Y-0.02%

ILLUMINA INC / ILMN FAQ

Can you provide the ChartMill fundamental rating for ILLUMINA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ILMN.


Can you provide the valuation status for ILLUMINA INC?

ChartMill assigns a valuation rating of 5 / 10 to ILLUMINA INC (ILMN). This can be considered as Fairly Valued.


How profitable is ILLUMINA INC (ILMN) stock?

ILLUMINA INC (ILMN) has a profitability rating of 7 / 10.


What is the financial health of ILLUMINA INC (ILMN) stock?

The financial health rating of ILLUMINA INC (ILMN) is 7 / 10.


What is the expected EPS growth for ILLUMINA INC (ILMN) stock?

The Earnings per Share (EPS) of ILLUMINA INC (ILMN) is expected to grow by 6.75% in the next year.